SpinalCyte was issued new patents in the U.S. and Japan. Five things to know: 1. SpinalCyte is a regenerative medicine company focused on spinal disc regrowth using human dermal fibroblasts. 2. The company’s CybroCell product is the first off-the-shelf allogenic human dermal fibroblast product. It’s used indegenerative disc disease treatments. 3. The patents describe methods to differentiate […]

Stem cell therapy development is a new area where several companies are emerging with promising results utilizing stem cell therapies. Some companies have failed, whereas others, such as Athersys, are succeeding. Gil Van Bokkelen, PhD, CEO of Athersys, will discuss his perspective on the recent advancements in stem cell therapies and their multiple application on […]

Health care’s digital transformation will take center stage in Orlando, Fla., next week at the industry’s most influential technology conference, a gathering whose exponential growth is a metaphor for the change sweeping through one of America’s biggest economic sectors.